Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on nearly $500 million in funding for the development of mRNA vaccines. The 22 projects are managed by the Biomedical Advanced Research and Development … Read more
On the five-year anniversary of the Covid pandemic, a Times reporter, Apoorva Mandavilli, looks back at the success of, and the backlash to, the mRNA vaccine. There’s no question that this vaccine technology saved millions of lives. But the vaccine couldn’t provide total protection against transmission or infection, and there were rare cases of side … Read more
Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the “immune imprinting” issue that has contributed to the declining effectiveness of boosters as the virus mutates. Immune imprinting, also known as original antigenic sin, occurs when the body’s original immune response to a virus — either from vaccination or infection — becomes … Read more
Imagine visiting your doctor for a routine checkup, and on top of the usual shots — the annual flu or COVID vaccine—your doctor asks if you’d like to be vaccinated for cancer. All cancer— lung, skin, colon, you name it — with just one mildly uncomfortable jab in the arm. That scenario, which sounds like … Read more
Florida Surgeon General Dr Joseph A Ladapo on Saturday (local time) recommended against receiving mRNA COVID-19 vaccines, especially to males aged 18 to 39 as it increases the risk of cardiac-related death. “Today, we released an analysis on COVID-19 mRNA vaccines the public needs to be aware of. This analysis showed an increased risk of … Read more
Summary Background Data on medium-term outcomes in indivduals with myocarditis after mRNA COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults. Methods In this follow-up surveillance study, we conducted surveys in US individuals … Read more
In a recently published study British Medical Journal (BMJ)Researchers evaluated the efficacy of a fourth dose of vaccine against coronavirus disease 2019 (COVID-19) among long-term care residents. Study: Effectiveness of the fourth dose of the COVID-19 mRNA vaccine against the Omicron variant among long-term care residents in Ontario, Canada: a trial negative design study. Image … Read more